Non‐Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis
Sign Up to like & getrecommendations! Published in 2019 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12361
Abstract: Mutant transthyretin (ATTRm) amyloidosis is a systemic disease caused by the deposition of amyloid fibrils derived from mutated transthyretin. Although cardiac involvement impacts the prognosis of patients with ATTRm amyloidosis, the incidence of cardiac events,… read more here.
Keywords: attrm amyloidosis; mutation septal; amyloidosis; non val30met ... See more keywords